Expanding Radiopharmaceutical Clinical Trials into Japan: Opportunities, Challenges & Lessons Learned from Trial Execution
1:30 pm - Tuesday 1st December 2026
- Understanding the key operational considerations for international developers seeking to establish radiopharmaceutical clinical trials in Japan
- Exploring how specialised clinical trial centres can support GMP-compliant investigational radiopharmaceutical manufacturing and PET-based clinical trial implementation, from early-phase biodistribution and dosimetry studies through Phase II/III programmes
- Sharing practical lessons learned from working with global pharmaceutical companies across diagnostic and therapeutic radiopharmaceutical programmes